3645 — Medical Net Cashflow Statement
0.000.00%
- ¥3bn
- ¥3bn
- ¥6bn
- 64
- 35
- 23
- 32
Annual cashflow statement for Medical Net, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.
2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | 2025 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | — | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 254 | 539 | 251 | 153 | 25.2 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 81.4 | -80 | 142 | 159 | 86.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 31.5 | -146 | -26.1 | -246 | -269 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 392 | 343 | 429 | 120 | -80.9 |
| Capital Expenditures | -13 | -2.17 | -20.6 | -32.8 | -132 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -75 | -353 | -41.7 | -253 | -128 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -88 | -355 | -62.4 | -285 | -260 |
| Financing Cash Flow Items | — | 1.05 | 0.239 | -0.002 | -0.025 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -34 | 282 | -17.9 | 144 | 219 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 273 | 260 | 385 | -5.64 | -104 |